BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 16619565)

  • 21. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer.
    Roof KS; Coen J; Lynch TJ; Wright C; Fidias P; Willett CG; Choi NC
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1120-8. PubMed ID: 16730135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001.
    Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
    Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
    Morota M; Gomi K; Kozuka T; Chin K; Matsuura M; Oguchi M; Ito H; Yamashita T
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):122-8. PubMed ID: 19327900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708).
    Kato H; Sato A; Fukuda H; Kagami Y; Udagawa H; Togo A; Ando N; Tanaka O; Shinoda M; Yamana H; Ishikura S
    Jpn J Clin Oncol; 2009 Oct; 39(10):638-43. PubMed ID: 19549720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consistency of variables in PCS and JASTRO great area database.
    Nishino T; Teshima T; Abe M; Ikeda H; Oguchi M; Hirokawa Y; Hiraoka M; Inoue T; Yamashita T; Nishio M; Niibe H; Mori T; Masuda K; Harauchi H; Inamura K
    Radiat Med; 1998; 16(6):449-55. PubMed ID: 9929145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer.
    Uno T; Isobe K; Kawakami H; Ueno N; Kobayashi H; Shimada H; Mastubara H; Okazumi S; Nabeya Y; Shiratori T; Ochiai T; Kawata T; Ito H
    Anticancer Res; 2004; 24(4):2483-6. PubMed ID: 15330202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials.
    Thomas CR; Berkey BA; Minsky BD; Gaspar LE; Herskovic A; Rich TA; Gunderson LL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1405-10. PubMed ID: 15050316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas.
    Toh Y; Ohga T; Itoh S; Kabashima A; Yamamoto K; Adachi E; Sakaguchi Y; Okamura T; Hirata H
    Anticancer Res; 2006; 26(3B):2487-91. PubMed ID: 16821637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
    Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
    Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage radiation therapy for residual superficial esophageal cancer after endoscopic mucosal resection.
    Nemoto K; Takai K; Ogawa Y; Sakayauchi T; Sugawara T; Jingu K; Wada H; Takai Y; Yamada S
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1290-4. PubMed ID: 16039069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
    J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma.
    Gao XS; Qiao XY; Yang XR; Asaumi J; Zhou ZG; Wang YD; Zhou DA; Wan J; Kuroda M; Kishi K; Kawasaki S; Hiraki Y
    Oncol Rep; 2002; 9(4):767-72. PubMed ID: 12066206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus.
    Kumar S; Dimri K; Khurana R; Rastogi N; Das KJ; Lal P
    Radiother Oncol; 2007 May; 83(2):139-47. PubMed ID: 17445928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T; Fuwa N; Kamata M; Furutani K; Tachibana H; Yamazaki T
    Anticancer Res; 2006; 26(1B):471-8. PubMed ID: 16739307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Percutaneous radiotherapy plus brachytherapy and concurrent chemotherapy for patients with localized esophageal carcinoma--Radiation Oncology Group Study 9207].
    Kovàcs G;
    Strahlenther Onkol; 2001 May; 177(5):269-70. PubMed ID: 11398614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.